Kinjal Amit Gosalia, Student

Kinjal Gosalia practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Kinjal Gosalia's NPI, 1073868873, was assigned on July 17, 2012. Kinjal Gosalia holds New York license 280391.

Kinjal Gosalia's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961 in Suffolk County. The practice phone is (631) 751-3000.

Kinjal Gosalia's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Kinjal Gosalia is also affiliated with Stony Brook University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Kinjal Gosalia to 3 more hospitals, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kinjal Gosalia practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Kinjal Gosalia's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Kinjal Gosalia is board certified in internal medicine by the American Board of Internal Medicine. Kinjal Gosalia is licensed in New York.

CMS data shows 4,721 Medicare services from Kinjal Gosalia across 35 procedure codes in 2024, for 689 Medicare patients. Medicare paid $341,993 for them.

CMS counts 689 Medicare patients who saw Kinjal Gosalia in 2024. The largest group is 75 to 84, with 282 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kinjal Gosalia's median patient age at 65, with 51% women.

In 2024, Kinjal Gosalia wrote 415 Medicare Part D claims for 122 patients. 77% of them were for generic drugs. CMS names the drug for 252 of them, across 10 drugs with 11 or more claims each, at $72,523 in total drug cost. In 2020, CMS named 69 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Kinjal Gosalia for performance year 2024, reported as part of a group. Kinjal Gosalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kinjal Gosalia as offering telehealth.

CMS Open Payments shows 29 general payments to Kinjal Gosalia from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 98% of the total. Travere Therapeutics, Inc. paid the most, $215.